Blood clots form in response to signals from the lungs of cancer patients—not from other organ sites, as previously ...

Blood clots form in response to signals from the lungs of cancer patients—not from other organ sites, as previously ...

Doctors are enrolling patients in a groundbreaking clinical trial aimed at reducing cancer recurrence in patients with ...

2024 — Researchers have developed a groundbreaking coating that could make medical devices safer for millions of patients, reducing the risks associated with blood clots and dangerous bleeding.

Novartis has brought abelacimab back into the fold. Six years after spinning the asset out to form Anthos Therapeutics, ...

University of Illinois Chicago scientists have redesigned a treatment for the most common pediatric leukemia to eliminate its ...

A bladder cancer diagnosis can be overwhelming bringing uncertainty and emotional distress Read on to learn the hopes and ...

UIC researchers have redesigned asparaginase, a key leukemia treatment, to reduce severe side effects like liver damage and ...